254 related articles for article (PubMed ID: 33918274)
1. Protein Binding Partners of Dysregulated miRNAs in Parkinson's Disease Serum.
Ruf WP; Freischmidt A; Grozdanov V; Roth V; Brockmann SJ; Mollenhauer B; Martin D; Haslinger B; Fundel-Clemens K; Otto M; Arnim CV; Holzmann K; Ludolph AC; Weishaupt JH; Danzer KM
Cells; 2021 Apr; 10(4):. PubMed ID: 33918274
[TBL] [Abstract][Full Text] [Related]
2. Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease.
He S; Huang L; Shao C; Nie T; Xia L; Cui B; Lu F; Zhu L; Chen B; Yang Q
Transl Neurodegener; 2021 Jul; 10(1):25. PubMed ID: 34315539
[TBL] [Abstract][Full Text] [Related]
3. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H
Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501
[TBL] [Abstract][Full Text] [Related]
4. Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study.
Manna I; Quattrone A; De Benedittis S; Vescio B; Iaccino E; Quattrone A
Parkinsonism Relat Disord; 2021 Dec; 93():77-84. PubMed ID: 34839044
[TBL] [Abstract][Full Text] [Related]
5. Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases.
Barbagallo C; Mostile G; Baglieri G; Giunta F; Luca A; Raciti L; Zappia M; Purrello M; Ragusa M; Nicoletti A
Cell Mol Neurobiol; 2020 May; 40(4):531-546. PubMed ID: 31691877
[TBL] [Abstract][Full Text] [Related]
6. Transcriptomics and Proteomics Approach for the Identification of Altered Blood microRNAs and Plasma Proteins in Parkinson's Disease.
Yadav SK; Jauhari A; Singh N; Pandey A; Sarkar S; Pandey S; Garg RK; Parmar D; Yadav S
Cell Mol Neurobiol; 2023 Oct; 43(7):3527-3553. PubMed ID: 37219663
[TBL] [Abstract][Full Text] [Related]
7. Serum miR-221 serves as a biomarker for Parkinson's disease.
Ma W; Li Y; Wang C; Xu F; Wang M; Liu Y
Cell Biochem Funct; 2016 Oct; 34(7):511-515. PubMed ID: 27748571
[TBL] [Abstract][Full Text] [Related]
8. Serum miR-30c-5p is a potential biomarker for multiple system atrophy.
Vallelunga A; Iannitti T; Dati G; Capece S; Maugeri M; Tocci E; Picillo M; Volpe G; Cozzolino A; Squillante M; Cicarelli G; Barone P; Pellecchia MT
Mol Biol Rep; 2019 Apr; 46(2):1661-1666. PubMed ID: 30810945
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
[TBL] [Abstract][Full Text] [Related]
10. Circulating Inflammatory miRNAs Associated with Parkinson's Disease Pathophysiology.
Oliveira SR; Dionísio PA; Correia Guedes L; Gonçalves N; Coelho M; Rosa MM; Amaral JD; Ferreira JJ; Rodrigues CMP
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32585840
[TBL] [Abstract][Full Text] [Related]
11. Circulating miR-155-5p as a Novel Biomarker of Lumbar Degenerative Disc Disease.
Divi SN; Markova DZ; Fang T; Guzek R; Kurd MF; Rihn JA; Hilibrand AS; Anderson DG; Vaccaro AR; Schroeder GD; Kepler CK
Spine (Phila Pa 1976); 2020 May; 45(9):E499-E507. PubMed ID: 31770330
[TBL] [Abstract][Full Text] [Related]
12. Differential expression and significance of miRNAs in plasma extracellular vesicles of patients with Parkinson's disease.
Xie S; Niu W; Xu F; Wang Y; Hu S; Niu C
Int J Neurosci; 2022 Jul; 132(7):673-688. PubMed ID: 33045885
[TBL] [Abstract][Full Text] [Related]
13. Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease.
Botta-Orfila T; Morató X; Compta Y; Lozano JJ; Falgàs N; Valldeoriola F; Pont-Sunyer C; Vilas D; Mengual L; Fernández M; Molinuevo JL; Antonell A; Martí MJ; Fernández-Santiago R; Ezquerra M
J Neurosci Res; 2014 Aug; 92(8):1071-7. PubMed ID: 24648008
[TBL] [Abstract][Full Text] [Related]
14. A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease.
Dong H; Wang C; Lu S; Yu C; Huang L; Feng W; Xu H; Chen X; Zen K; Yan Q; Liu W; Zhang C; Zhang CY
Biomarkers; 2016; 21(2):129-37. PubMed ID: 26631297
[TBL] [Abstract][Full Text] [Related]
15. Role and Dysregulation of miRNA in Patients with Parkinson's Disease.
Salemi M; Marchese G; Lanza G; Cosentino FII; Salluzzo MG; Schillaci FA; Ventola GM; Cordella A; Ravo M; Ferri R
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614153
[TBL] [Abstract][Full Text] [Related]
16. Expression Profiling of Blood microRNAs 885, 361, and 17 in the Patients with the Parkinson's disease: Integrating Interaction Data to Uncover the Possible Triggering Age-Related Mechanisms.
Behbahanipour M; Peymani M; Salari M; Hashemi MS; Nasr-Esfahani MH; Ghaedi K
Sci Rep; 2019 Sep; 9(1):13759. PubMed ID: 31551498
[TBL] [Abstract][Full Text] [Related]
17. Identification of blood microRNAs associated to Parkinsonĭs disease.
Margis R; Margis R; Rieder CR
J Biotechnol; 2011 Mar; 152(3):96-101. PubMed ID: 21295623
[TBL] [Abstract][Full Text] [Related]
18. Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease.
Ding H; Huang Z; Chen M; Wang C; Chen X; Chen J; Zhang J
Parkinsonism Relat Disord; 2016 Jan; 22():68-73. PubMed ID: 26631952
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA‑34a‑5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study.
Grossi I; Radeghieri A; Paolini L; Porrini V; Pilotto A; Padovani A; Marengoni A; Barbon A; Bellucci A; Pizzi M; Salvi A; De Petro G
Int J Mol Med; 2021 Feb; 47(2):533-546. PubMed ID: 33416118
[TBL] [Abstract][Full Text] [Related]
20. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.
Gui Y; Liu H; Zhang L; Lv W; Hu X
Oncotarget; 2015 Nov; 6(35):37043-53. PubMed ID: 26497684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
